- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07448532
Comparative Effects of Functional Electrical Stimulation and Mirror Therapy for Foot Clearance Among Patients With Sub-acute Stroke (FES MT CVA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nabeela Dawood
- Phone Number: +923315337445
- Email: nabeela.dawood@ubas.edu.pk
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Recruiting
- Lahore University of Biological and Applied Sciences
-
Contact:
- Shoaib Prof. Dr. Waqas, PhD
- Phone Number: 03024552109
- Email: shoaib.waqas@ubas.edu.pk
-
Principal Investigator:
- Rohma Shah, Doctor of Physical Therapy
-
Sub-Investigator:
- Rabiya Haroon, Doctor of Physical Therapy
-
Sub-Investigator:
- Ayesha Hassan, Doctor of Physical Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient aged 18-85 years of age, who experienced stroke within ≤6 months.
- The Fugl-Meyer motor assessment of lower extremity (FMA-LE) was conducted by physiotherapist in the hospital, and score required to be ≥ 20 points.
- Participants possessed healthy nerves, neuromuscular junctions, muscles tissues, and a sufficient range of motion in dorsiflexor and plantarflexion.
- The subjects could walk independently on a treadmill for at least 2 min without without experiencing adverse reaction to FES.
- Patients who received more 24 scores on Mini Mental State Exam and could comprehend and follow the information researcher provides.
- No orthopedic diseases in upper and lower extremities.
- Patients with functional ambulation classification (FAC) score of 3 or 4 were included (FAC is a scale of 0-5, where 3 indicates supervision or standby guarding and 4 indicates independent on level surfaces.
- Patients with inadequate ankle dorsiflexion during the swing phase of gait.
- Patients with adequate minimal stability at the ankle during stance with stimulation.
Exclusion Criteria:
- Patients with cardiac pacemaker, those with skin lesions, who could not be treated due to spasticity within the last three months, and vestibular and cerebellar lesions or deaf- blindness were excluded.
- Patients with past or current epilepsy, uncontrolled seizure disorder, mental disorders and all neurological disorders except stroke.
- Patients with severe edema of lower extremities or patients of vascular disorders like deep vein thrombosis or thromboembolisms and severe atheroscelerosis of lower extremities.
- Subjects with any musculoskeletal dysfunction that would potentially affect gait and causes risk of falls.
- We excluded patients with pregnancy, plantar flexion contracture, and severe hemi-neglect.
- Subjects with hip or knee prostheses made of metal on the lower limb were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A (Functional Electrical Stimulation and Routine Physical Therapy)
Functional Electrical Stimulation (FES) in combination with Routine Physical Therapy. The interventions will be administered three times per week over a four-week period. Each session will last 50 minutes. Functional Electrical Stimulation will be applied to the affected lower limb, primarily targeting muscles responsible for ankle dorsiflexion, to facilitate improved foot clearance during gait. In addition to FES, participants will undergo Routine Physical Therapy consisting of stretching exercises, strengthening exercises, and repeated task-oriented gait training aimed at improving functional ambulation. Routine Physical Therapy will be provided for 20 minutes per session, while FES will be applied for 30 minutes, making a total session duration of 50 minutes. This arm aims to assess the effects of neuromodulation through peripheral electrical stimulation on foot clearance and gait performance in sub-acute stroke patients. |
Functional Electrical Stimulation was administered to participants in the experimental group to facilitate activation of the ankle dorsiflexor muscles, primarily the tibialis anterior, to improve impaired foot clearance in sub-acute stroke patients. Surface electrodes were placed over the tibialis anterior muscle of the affected limb to elicit ankle dorsiflexion. Electrical stimulation was delivered at an intensity sufficient to produce visible and functional ankle dorsiflexion without causing discomfort. The stimulation aimed to enhance neuromuscular recruitment, improve voluntary motor control, and promote motor relearning through repeated activation of the weakened muscles during functional tasks. Each FES session lasted 30 minutes, followed by 20 minutes of routine physical.
Other Names:
|
|
Active Comparator: Group B (Mirror Therapy and Routine Physical Therapy)
Group B will receive Mirror Therapy in combination with Routine Physical Therapy. The interventions will be administered three times per week over a four-week period, with each session lasting 50 minutes. Mirror Therapy will involve participants performing movements of the unaffected lower limb while observing its reflection in a mirror placed in the sagittal plane, creating the illusion that the affected limb is moving normally. This intervention is intended to enhance sensory feedback and promote motor recovery through visual input. Alongside Mirror Therapy, participants will receive Routine Physical Therapy consisting of stretching, strengthening exercises, and repeated task-oriented gait training. Routine Physical Therapy will be provided for 20 minutes, while Mirror Therapy will be conducted for 30 minutes per session, resulting in a total treatment duration of 50 minutes. This arm aims to evaluate the effects of sensory augmentation through visual feedback on foot clearance and |
Mirror Therapy was administered to participants in the comparison group as a sensory augmentation intervention to enhance motor recovery through visual feedback. A vertical mirror was placed between the lower limbs in the sagittal plane, such that the reflection of the non-paretic limb was visible while the paretic limb was concealed from view. Participants were instructed to perform repeated ankle dorsiflexion and plantarflexion movements with the non-paretic limb while observing its reflection in the mirror. This created the visual illusion that the paretic limb was moving normally, providing visual feedback to the brain. Mirror Therapy aims to stimulate mirror neuron systems and sensorimotor cortical areas, encouraging cortical reorganization and improved motor control of the affected limb. During the session, the paretic limb remained relaxed while the participant focused on the mirror image. Each Mirror Therapy session lasted 30 minutes, followed by 20 minutes of routine physical
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Foot Clearance
Time Frame: From the enrollment to the end of treatment at 4 weeks
|
Sub-acute stroke survivors present with hemi-paretic gait often presents with reduced hip, knee, and ankle flexion during swing phase along with decreased joint motion and power in late stance and pre-swing phase.
These impairments result in making foot clearance more difficult.
A crucial walking measure that signals tripping is minimum foot clearance (MFC), which takes place in the mid-swing phase of the gait cycle in our study we intend to improve foot clearance in subacute stroke survivors primarily.
The tool used for this purpose is Fugl-Meyer Assessment (FMA) a comprehensive, standardized tool used to assess motor function recovery in stroke patients, focusing on the lower limb, balance, and sensory function.
The outcomes that were studied in stroke patients are foot clearance and improvement in ADLs.
This tool is stroke-specific, performance-based scale designed to evaluate motor recovery, with the Lower Extremity subscale assessing hip, knee, and ankle function, including ankle
|
From the enrollment to the end of treatment at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Activity of Daily Living (ADLs)
Time Frame: From the enrollment to the end of treatment at 4 weeks
|
Stroke survivors need some assistance or are fully dependent on their caregivers for activities of daily living (ADLs).
Reduced stroke hospitalization and efficiency-driven care increase the need for early prognosis of basic ADL outcomes (e.g., dressing, mobility, bathing) to optimize early stroke management.
Our secondary outcome is improvement in ADLs for which we have used Functional Independence Measure (FIM) is one of the most widely used outcome measures in stroke rehabilitation.
The Motor-FIM, which includes items related to transfers, locomotion, and stair climbing, is particularly relevant to mobility outcomes.
The FIM demonstrates excellent internal consistency, with Cronbach's alpha values reported between 0.93 and 0.95 for the total scale, and approximately 0.95 for the motor subscale.
These findings confirm that the FIM is a reliable and valid instrument for assessing functional independence in ADLs and mobility performance among stroke patients.
|
From the enrollment to the end of treatment at 4 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: Nabeela Dawood, Lahore University of Biological and Applied Sciences
- Principal Investigator: Rohma Shah, Lahore College of Physical therapy
- Principal Investigator: Ayesha Hassan, Lahore College of Physical therapy
- Principal Investigator: Rabiya Haroon, Lahore College of Physical therapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Stroke
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Therapeutics
- Pharmacologic Actions
- Chemical Actions and Uses
- Physical Therapy Modalities
- Rehabilitation
- Neurotransmitter Agents
- Mirror Movement Therapy
Other Study ID Numbers
- DPT/ERB/26
- U1111-1334-2744 (Registry Identifier: Rohma Shah)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke (Subacute)
-
Trịnh Minh TúRecruiting
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of CalgaryRecruitingStroke | Stroke Gait Rehabilitation | Subacute Stroke | Stroke (Subacute)Canada
-
Francesca CecchiUniversity of Florence; Carol Davila University of Medicine and Pharmacy; Roessingh... and other collaboratorsNot yet recruitingSubacute Stroke | Stroke; SubacuteItaly
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University of LahoreCompletedStroke | Subacute StrokePakistan
-
University of LahoreEnrolling by invitationStroke (Subacute)Pakistan
-
Majmaah UniversityNot yet recruitingStroke (Subacute)
Clinical Trials on Neuromodulators
-
Universidad Nacional Andres BelloNot yet recruiting
-
RenJi HospitalRecruitingDyspepsia | Functional Gastrointestinal Disorders | Psychosomatic DisorderChina